Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Showing results for

Malaria is a leading cause of death and illness around the world. Over 200 million cases are reported every year, and more than 400 000 people die. More than 90% of cases are reported in sub-Saharan Africa. Scientists have spent decades searching for an effective vaccine. Hence the recent excitement when Malawi’s government announced it had launched a pilot programme for the world’s first malaria vaccine, RTS,S (also known as Mosquirix©), produced by the pharmaceutical company, GSK. It’s the first vaccine to demonstrate significant reduction in malaria in children. The Conversation Africa’s Ina Skosana asked immunologist Faith Osier about RTS,S.

The Conversation logo

30 years of MORU research in Rickettsioses featured in ESCMID 2026 keynote

MORU was well represented at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 2026 conference, held from 17-21 April in Munich.

Expert Comment: World Malaria Day 2026 - Malaria vs the Data Collective

Millions of African children receive preventative antimalarial drugs during the yearly malaria ‘high season’, a strategy aimed at reducing the annual toll of 600,000 malaria deaths worldwide – most of these deaths are children in Sub-Saharan Africa. IDDO DPhil student Dhruv Darji is using the collective power of data to find ways to make this preventative treatment better, including understanding interactions with the many real-world factors that health policy makers grapple with.

Innovative housing design cools homes, saves lives in Africa

Simple improvements in housing can have a profound impact on public health in sub-Saharan Africa, say researchers who designed Star Home, a novel double-story house that provides an insect-proof, cleaner, cooler and smoke-free environment with reliable water and sanitation in Tanzania.

OUCRU joins WHO Coronavirus Network

OUCRU, hosted by the Hospital for Tropical Diseases (HTD) in Ho Chi Minh City, Vietnam, has joined the World Health Organisation (WHO) Coronavirus Network (CoViNet), a global network to detect and monitor coronaviruses of public health importance.

From MODRA to Wellcome Sanger Fellowship: Dr Le Thanh Hoang Nhat reflects on Growth and Connection

Dr Nhat, a MODRA alumnus, has been awarded a Wellcome Sanger Fellowship. Reflecting on his journey, he highlights how mentorship, regional collaboration and focused training through MODRA helped shape a competitive research proposal and strengthen his direction as an independent researcher.

Reimagining community mental health in Kenya through the 'Nyumba Kumi' model

A new community-based mental health approach in Kenya draws on the Nyumba Kumi model, where trusted local elders support small household groups. Combining cultural practice with psychological research, the project aims to address limited access to care by enabling early intervention and prevention, empowering communities to take a leading role in improving mental well-being.

Integration of Infection Prevention and Control into the Antimicrobial Stewardship Programme – 60HN ASPARNet

The study titled “Evaluating Antimicrobial Stewardship strategies and capacity building through Participatory Action Research and a Network approach in Vietnam” (60HN – ASPARNet) continues to implement key activities to promote AMS programmes across hospitals participating in the network.

GRAM to host 27th and 29th April webinar on AMR insights for policy

The Global Research on Antimicrobial Resistance (GRAM) Project is inviting global AMR stakeholders to attend its 27th and 29th April webinar, ‘Information to action: Antimicrobial resistance insights for policy’. Led by GRAM partners at IHME, the session will explore successful interventions to combat AMR, and conclude with a demonstration of data tools that may assist policymakers and researchers in quantifying the impact of interventions targeting AMR.

Study brings together prognostic models for visceral leishmaniasis outcomes

A BMJ Public Health review by IDDO researchers analysed 12 prognostic models for visceral leishmaniasis, identifying significant gaps and high risk of bias. Developed mainly in Brazil and East Africa, these models lack applicability in high-burden regions like the Indian subcontinent. The findings support improved model development and better-informed clinical decision-making.

IHTM students take policy briefs to UK Parliament

11th cohort of students present to Parliament on global health's most pressing challenges

New £5 million Wellcome Discovery Award to transform treatment for tuberculous meningitis

Tuberculous meningitis remains highly lethal despite standard treatment, and recent trials show current antibiotic and corticosteroid approaches are not good enough. A new international research programme, funded by Wellcome, aims to develop improved therapies by studying disease mechanisms, testing novel drugs and identifying biomarkers, aiming to guide safer, more effective treatment and reduce global deaths.

Championing Ethical Research: Dorcas Kamuya on Community, Science, and Women in Leadership

Dorcas Kamuya’s journey highlights the impact of ethical, community-centred research. From rural Kenya to scientific leadership, she champions equity, mentorship, and inclusive research practices. Her work ensures that science respects community voices while advancing health systems, inspiring the next generation of women in research.

Advancing Epilepsy Care in Africa: Insights from the EPInA Dissemination Meeting in Nairobi

The EPInA project (Epilepsy Pathway Innovations in Africa) convened stakeholders in Nairobi to advance epilepsy care across Africa, supporting WHO’s Intersectoral Global Action Plan framework. Through community engagement and digital innovation, the initiative improves diagnosis, treatment and stigma reduction. The meeting emphasised translating evidence into action, strengthening health systems, and expanding access to equitable neurological care.

Strengthening intensive care capacity in Vietnam through international training

OUCRU held its annual intensive care training for healthcare workers on 12–13 March 2026 in Ho Chi Minh City. The two-day programme brought together specialists from the UK and Vietnam to share the latest knowledge and skills in critical care medicine.

Oxford and Serum Institute of India sign IP license agreement to advance NipahB vaccine candidate

The University of Oxford and Serum Institute of India Pvt. Ltd. (SII), a Cyrus Poonawalla Group company and the world’s largest vaccine manufacturer, have signed an Intellectual Property license agreement to advance the development and manufacture of the ChAdOx1 NipahB vaccine candidate. Professor Brian Angus is Chief Investigator of the trial.

From Factory Worker to Infectious Diseases Scientist: The Story of OUCRU Indonesia’s Suwarti

OUCRU Indonesia highlights the remarkable journey of Dr Suwarti, a scientist who rose from factory work to infectious diseases research. Through determination, education, and mentorship, Suwarti built a scientific career addressing critical public health challenges. Her story reflects OUCRU’s commitment to developing local research talent and expanding scientific opportunity in Indonesia.

Behind the Title: Becoming an Oxford Professor (at NDM), featuring Professor Phaik Yeong Cheah

The Behind the Title: Becoming an Oxford Professor (at NDM) series highlights the diverse journeys of our professors and the many paths that lead to academic leadership. By sharing their journeys we aim to showcase the breadth of backgrounds, disciplines, and experiences represented across the Department, demonstrating that there is no single route to becoming a professor at Oxford. In our first feature, we hear from Professor Phaik Yeong Cheah, Head of Bioethics and Engagement at the Mahidol Oxford Tropical Medicine Research Unit (MORU), Nuffield Department of Medicine, based in Bangkok.

Oxford joins new West Africa consortium to accelerate climate and health solutions

Researchers from the University of Oxford have joined African universities and regional experts who are working with Wellcome to establish new science and policy consortiums that will address the escalating public health crisis driven by climate change - saving lives and livelihoods.

Why the Way We Use Antibiotics Matters More Than We Think

Antimicrobial resistance is a growing global threat driven by everyday antibiotic use, especially in informal healthcare settings. In rural Vietnam, women caregivers often rely on antibiotics to manage common symptoms amid limited healthcare access. Collab Lab highlights how social context, uncertainty and caregiving pressures shape antibiotic decisions and contribute to rising resistance.

Strengthening Pharmacy resilience in public health crises in Nigeria

Dr Rachel Obonose Titus developed evidence-based Standard Operating Procedures (SOPs) to strengthen Nigerian community pharmacies during public health emergencies. Inspired by COVID-19 challenges, her work translates frontline experiences into practical policy tools. Through an AfOx Visiting Fellowship, she advanced evaluation and stakeholder engagement, aiming for national adoption and improved health system resilience.

Load More

Similar stories